In Vitro to In Vivo Extrapolation (IVIVE) for human health risk assessment

被引：0
|
作者：
Conolly, R.
McMullin, T. [1 ]
Hines, R. N.
Sheets, L. P. [2 ]
Cohen, S. M. [3 ]
机构：
[1] Dow Corning Corp, Midland, MI USA
[2] Bayer CropSci, Res Triangle Pk, NC USA
[3] Univ Nebraska Med Ctr, Omaha, NE USA
来源：
TOXICOLOGY LETTERS | 2013年 / 221卷
关键词：
D O I：
10.1016/j.toxlet.2013.06.051
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [41] Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways
    Benet, Leslie Z.
    Sodhi, Jasleen K.
    AAPS JOURNAL, 2020, 22 (05):
  • [42] GENOTYPE-BASED IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) OF EFAVIRENZ PHARMACOKINETICS USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL
    Xu, C.
    Quinney, S.
    Guo, Y.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S30 - S30
  • [43] In Vitro-In Vivo Extrapolation (IVIVE) of Genetic Toxicity New Approach Methodology (NAM) Data: A HESI-GTTC Case Study
    Long, Alexandra S.
    Beal, Marc A.
    Sangion, Alessandro
    Armitage, James
    Arnot, Jon
    White, Paul A.
    Barton-Maclaren, Tara S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2023, 64 : 46 - 47
  • [44] Using in Vitro-In Vivo Extrapolation to Predict Human Clearance
    Wang X.
    Wang, Xiangling, 1600, Mary Ann Liebert Inc. (41): : 78 - 79
  • [45] APPLICATION OF IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) TO INVESTIGATE THE RATE-DETERMINING STEPS IN THE HEPATIC CLEARANCE OF HIV PROTEASE INHIBITORS IN RAT
    De Bruyn, Tom
    Augustijns, Patrick
    Annaert, Pieter
    DRUG METABOLISM REVIEWS, 2014, 45 : 165 - 165
  • [46] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation
    Daniel Scotcher
    Christopher Jones
    Maria Posada
    Aleksandra Galetin
    Amin Rostami-Hodjegan
    The AAPS Journal, 2016, 18 : 1082 - 1094
  • [47] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation
    Scotcher, Daniel
    Jones, Christopher
    Posada, Maria
    Galetin, Aleksandra
    Rostami-Hodjegan, Amin
    AAPS JOURNAL, 2016, 18 (05): : 1082 - 1094
  • [48] Application of adverse outcome pathways and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for risk assessment based on in vitro data
    Mally, A.
    Birk, B.
    Di Fiore, S.
    Ellinger, B.
    Jarzina, S.
    Reiser, P.
    Taverne, F.
    Kramer, N.
    TOXICOLOGY LETTERS, 2019, 314 : S140 - S140
  • [49] Parametrisation and interpretation of IVIVE-PBK in risk assessment
    Jo, H.
    TOXICOLOGY LETTERS, 2022, 368 : S15 - S15
  • [50] Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research
    Li, Na
    Badrinarayanan, Akshay
    Ishida, Kazuya
    Li, Xingwen
    Roberts, John
    Wang, Shuai
    Hayashi, Mike
    Gupta, Anshul
    AAPS JOURNAL, 2020, 23 (01):
12345